{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:12:07Z","timestamp":1791403927708,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.pbb.2017.12.006","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T18:14:53Z","timestamp":1513707293000},"page":"9-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D 2 and 5-HT 2A receptors: Implications for obsessive\u2013compulsive disorder"],"prefix":"10.1016","volume":"165","author":[{"given":"Nobuaki","family":"Egashira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8595-5820","authenticated-orcid":false,"given":"Shutaro","family":"Katsurabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2017.12.006_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth ed. DSM-5","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1016\/j.pbb.2017.12.006_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2017.12.006_bb0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11302-015-9467-2","article-title":"Paroxetine suppresses recombinant human P2X7 responses","volume":"11","author":"Dao-Ung","year":"2015","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.pbb.2017.12.006_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S1461145712000740","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"16","author":"Dold","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2017.12.006_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.02.019","article-title":"Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine","volume":"563","author":"Egashira","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2017.12.006_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1254\/jphs.08160SC","article-title":"Calcium-channel antagonists inhibit marble-burying behavior in mice","volume":"108","author":"Egashira","year":"2008","journal-title":"J. Pharmacol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2017.12.006_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2008.06.100","article-title":"Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms","volume":"592","author":"Egashira","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2017.12.006_bb0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1248\/bpb.35.376","article-title":"Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice","volume":"35","author":"Egashira","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.pbb.2017.12.006_bb0045","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","article-title":"Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review","volume":"67","author":"Gao","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2017.12.006_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","article-title":"Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8 Suppl 1","key":"10.1016\/j.pbb.2017.12.006_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852900006908","article-title":"WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults","volume":"8","author":"Greist","year":"2003","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.pbb.2017.12.006_bb0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bjp.0706108","article-title":"Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors","volume":"144","author":"Hirano","year":"2005","journal-title":"Brit. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2017.12.006_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jjp.68.65","article-title":"5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice","volume":"68","author":"Ichimaru","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2017.12.006_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a well-known antipsychotic, inhibits glioblastoma invasion by binding to calmodulin and disinhibiting calcium release channel IP3R","volume":"16","author":"Kang","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"26","key":"10.1016\/j.pbb.2017.12.006_bb0075","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/S0024-3205(99)00203-9","article-title":"Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice","volume":"64","author":"Kim","year":"1999","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.pbb.2017.12.006_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-4328(97)00162-9","article-title":"Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour","volume":"94","author":"Londei","year":"1998","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2017.12.006_bb0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1254\/jphs.FP0050144","article-title":"Perospirone, a novel antipsychotic drugs, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder","volume":"99","author":"Matsushita","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2017.12.006_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.physbeh.2016.11.002","article-title":"Strain and sex based characterization of behavioral expressions in non-induced compulsive-like mice","volume":"168","author":"Mitra","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2017.12.006_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2016.00244","article-title":"Attenuation of compulsive-like behavior through positive allosteric modulation of \u03b14\u03b22 nicotinic acetylcholine receptors in non-induced compulsive-like mice","volume":"10","author":"Mitra","year":"2017","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2017.12.006_bb0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pnpbp.2005.11.010","article-title":"Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse","volume":"30","author":"Nilsson","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2017.12.006_bb0105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)33233-7","article-title":"Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships","volume":"222","author":"Prozialeck","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2017.12.006_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/mol.114.096941","article-title":"Repurposing the antipsychotic trifluoperazine as an antimetastasis agent","volume":"87","author":"Pulkoski-Gross","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2017.12.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-8-26","article-title":"Inhibition of Ca2+\/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats","volume":"8","author":"Shirahama","year":"2012","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.pbb.2017.12.006_bb0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2017.12.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157232","article-title":"Calcium signaling pathway is associated with the long-term clinical response to selective serotonin reuptake inhibitors (SSRI) and SSRI with antipsychotics in patients with obsessive-compulsive disorder","volume":"11","author":"Umehara","year":"2016","journal-title":"PLoS One"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305717306135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305717306135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:50:49Z","timestamp":1751158249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305717306135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":25,"alternative-id":["S0091305717306135"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2017.12.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antipsychotic trifluoperazine reduces marble-burying behavior in mice via D2 and 5-HT2A receptors: Implications for obsessive\u2013compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}